DexCom (DXCM) Earnings Date, Estimates & Call Transcripts $67.29 -0.24 (-0.36%) (As of 09/27/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateOct. 24After Market ClosesConfirmedActual EPS (Jul. 25) $0.43 Beat By $0.04 Consensus EPS (Jul. 25) $0.39 Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckSEC 10-Q/10-K Filing Get DexCom Earnings AlertsEnter your email address below to receive the latest news and earnings results for DXCM and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueDXCM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.DXCM Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the MarketsNOTICE: You have until Tuesday, November 19thOn Tuesday, November 19, 2024 smart investors will collect their share of a $1.2 billion windfall... It's part of a unique strategy which has nothing to do with risky investments like options, cryptos or forex. And while it might sound crazy...Click here for the ticker >>> DexCom Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243$0.25$0.33$0.28 Q2 20243$0.34$0.45$0.39 Q3 20243$0.39$0.45$0.42 Q4 20243$0.42$0.53$0.48 FY 202412$1.40$1.76$1.57 Q1 20253$0.31$0.39$0.36 Q2 20253$0.47$0.55$0.50 Q3 20252$0.52$0.61$0.57 Q4 20252$0.69$0.69$0.69 FY 202510$1.99$2.24 $2.11DXCM Earnings Date and InformationDexCom last announced its earnings data on July 25th, 2024. The medical device company reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.04. The company earned $1 billion during the quarter, compared to the consensus estimate of $1.04 billion. Its revenue for the quarter was up 15.3% on a year-over-year basis. DexCom has generated $1.55 earnings per share over the last year ($1.55 diluted earnings per share) and currently has a price-to-earnings ratio of 43.4. Earnings for DexCom are expected to grow by 18.93% in the coming year, from $1.69 to $2.01 per share. DexCom has confirmed that its next quarterly earnings report will be published on Thursday, October 24th, 2024. DexCom will be holding an earnings conference call on Thursday, October 24th at 4:30 PM Eastern. Interested parties can register for or listen to the call.. Read More DexCom Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 10/24/2024(Confirmed)------- 7/25/2024Q2 2024$0.39$0.43+$0.04$0.51$1.04 billion$1.00 billion 4/25/2024Q1 2024$0.27$0.32+$0.05$0.28$911.20 million$921.00 million 2/8/2024Q4 2023$0.43$0.50+$0.07$0.38$1.02 billion$1.03 billion 10/26/2023Q3 2023$0.34$0.50+$0.16$0.71$939.64 million$975.00 million 7/27/2023Q2 2023$0.22$0.34+$0.12$0.40$841.16 million$871.30 million 4/27/2023Q1 2023$0.15$0.17+$0.02$0.22$720.52 million$7.45 billion Get the Latest News and Ratings for DXCM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DexCom and its competitors with MarketBeat's FREE daily newsletter. 2/9/2023Q4 2022$0.26$0.34+$0.08$0.46$814.52 million$815.20 million 10/27/2022Q3 2022$0.24$0.28+$0.04$0.32$752.67 million$769.60 million 7/28/2022Q2 2022$0.17$0.17-$0.22$709.33 million$696.20 million 4/28/2022Q1 2022$0.1250$0.08($0.0450)($0.29)$623.97 million$628.80 million 2/10/2022Q4 2021$0.2150$0.17($0.0450)$1.56$698.66 million$698.20 million 10/28/2021Q3 2021$0.1550$0.2225+$0.0675$1.07$617.07 million$650.20 million 7/29/2021Q2 2021$0.1075$0.19+$0.0825$0.89$548.02 million$595.10 million 4/29/2021Q1 2021$0.0775$0.0825+$0.0050$0.25$482.67 million$505.00 million 2/11/2021Q4 2020$0.2275$0.2275-($1.66)$558.41 million$568.90 million 10/27/2020Q3 2020$0.16$0.2350+$0.0750$1.15$477.22 million$500.90 million 7/28/2020Q2 2020$0.0775$0.1975+$0.12$1.10$415.21 million$451.80 million 4/28/2020Q1 2020$0.0375$0.11+$0.0725$0.67$358.34 million$405.10 million 2/13/2020Q4 2019$0.1850$0.2875+$0.1025$1.30$457.00 million$462.80 million 11/6/2019Q3 2019$0.05$0.1625+$0.1125$0.80$348.99 million$396.30 million DexCom Earnings - Frequently Asked Questions When is DexCom's earnings date? DexCom has confirmed that its next quarterly earnings data will be published on Thursday, October 24th, 2024. Learn more on DXCM's earnings history. What guidance has DexCom issued on next quarter's earnings? DexCom issued an update on its FY 2024 earnings guidance on Thursday, July, 25th. The company issued revenue guidance of $4.0 billion-$4.1 billion, compared to the consensus revenue estimate of $4.3 billion. Did DexCom beat their earnings estimates last quarter? In the previous quarter, DexCom (NASDAQ:DXCM) reported $0.43 earnings per share (EPS) to beat the analysts' consensus estimate of $0.39 by $0.04. Learn more on analysts' earnings estimate vs. DXCM's actual earnings. How can I listen to DexCom's earnings conference call? The conference call for DexCom's latest earnings report can be listened to online. Listen to Conference Call How can I read DexCom's conference call transcript? The conference call transcript for DexCom's latest earnings report can be read online. Read Transcript How can I view DexCom's earnings report? DexCom's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does DexCom generate each year? DexCom (NASDAQ:DXCM) has a recorded annual revenue of $3.93 billion. How much profit does DexCom generate each year? DexCom (NASDAQ:DXCM) has a recorded net income of $541.50 million. DXCM has generated $1.55 earnings per share over the last four quarters. What is DexCom's price-to-earnings ratio? DexCom (NASDAQ:DXCM) has a trailing price-to-earnings ratio of 43.41 and a forward price-to-earnings ratio of 39.82. The price/earnings-to-growth ratio is 2.16. What is DexCom's EPS forecast for next year? DexCom's earnings are expected to grow from $1.69 per share to $2.01 per share in the next year, which is a 18.93% increase. More Earnings Resources from MarketBeat Related Companies: NovoCure Earnings Results Becton, Dickinson and Company Earnings Results IDEXX Laboratories Earnings Results Edwards Lifesciences Earnings Results ResMed Earnings Results STERIS Earnings Results Baxter International Earnings Results Hologic Earnings Results Insulet Earnings Results Teleflex Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Micron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit Outlook This page (NASDAQ:DXCM) was last updated on 9/28/2024 by MarketBeat.com Staff From Our Partners10X More Profitable Than Physical Gold?The smart money is piling into gold and gold stocks. There's a backdoor gold play that could deliver 10 TIM...Monument Traders Alliance | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredThe Standard Oil of AI?ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT m...Behind the Markets | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DexCom, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DexCom With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.